Article info

Extended report
Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial

Authors

  1. Correspondence to Professor PG Conaghan, Division of Musculoskeletal Disease, Chapel Allerton Hospital, Leeds LS7 4SA, UK; p.conaghan{at}leeds.ac.uk
View Full Text

Citation

Conaghan PG, Durez P, Alten RE, et al
Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial

Publication history

  • Received February 29, 2012
  • Accepted July 19, 2012
  • First published August 21, 2012.
Online issue publication 
July 04, 2013

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.